Navigation Links
From Donuts To Hogs - Which Brand Icons Might Be In Play?
Date:3/17/2010

op5,eVar3,prop15';s.prop5='External Link';s.eVar3=s.prop5;s.prop15='88198142';s.tl(this,'o','ExternalLink');" target='_blank' href="http://www.efinancialnews.com/search?q=sanofi-aventis">Sanofi-Aventis, GlaxoSmithKline and Johnson & Johnson."

Jacob Plieth, a Dow Jones Investment Banker columnist, predicts an acquisition of Vivus. "Qnexa, a drug for treating obesity, has been filed with the FDA by Vivus. The possible market for an efficacious weight loss drug with a decent safety profile is over $1 billion, and Qnexa is the most efficacious of a new wave of obesity products, all of which need big pharmaceutical partners to be marketed to primary prescribers. This makes Vivus a leading contender for acquisition potentially by Johnson & Johnson, Bristol-Myers Squibb, or other big pharmaceutical companies that have worked in obesity before and still see it as a promising area."

Automotive

Dow Jones Investment Banker senior columnist Ed Tan says that Harley-Davidson has suffered a decline
'/>"/>

SOURCE Dow Jones & Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Atacama Labs Enters Into Partnership With Excella Gmbh, Which is Part of Fareva Holding, a Top 10 Global Contract Manufacturer
2. New Research Reveals Mechanism By Which TNFerade(TM) Suppresses Metastases
3. FluForecast(R) Replikin Count(TM) Predicts That the H5N1 Cycle Which Began in 1996 Is Now Over
4. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
5. Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States
6. Sigma-Aldrich(R) Focuses on Biology With Launch of New Life Science Brand Platform
7. Spectrum Introduces New Line of Spectrum Branded Benchtop Laboratory Equipment
8. DuPont Congratulates Wright for Highest Overall Yield with Pioneer Brand Hybrid 32N73 in 2009 NCGA Corn Yield Contest
9. Sporicidin Brand Disinfectant Kills H1N1 in 3 Minutes
10. Hypertension Drug Market Will Experience Only Modest Annual Decline Through 2018, Despite Generic Erosion Of Many Branded Agents
11. American Oriental Bioengineerings Jinji Capsules and Boke Nasal Spray Designated Among Chinas Top Branded Drugs of 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , June 29, 2015 ... has announced the addition of the "Biotechnology ... Biotechnology for the Non-Biotechnologist, ideal for ... theory, principles, techniques and potential of biotechnology. ... understand the basic theory, principles, techniques, and potential ...
(Date:7/6/2015)... ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) ... Novella Clinical (Novella), to conduct the phase 3 ... glioblastoma. Novella is a full-service, global clinical research organization ... oncology companies. The ICT-107 phase 3 trial will include ... Europe and Canada , ...
(Date:7/3/2015)... , July 3, 2015 /PRNewswire/ ... hakea verkossa osoitteessa  http://www.openinnovationinscience.at ... Innovation in Science" -jatkokoulutusohjelmaan 22.7.2015 ... Gesellschaftin (LBG) tekemän, kansainvälisiä tutkijoita ... terveystieteiden kaksi suurinta haastetta ovat ...
(Date:7/3/2015)... , July 3, 2015 ... till 22 september 2015 på  http://www.openinnovationinscience.at ... Innovation in Science" som hålls i ... en färsk undersökning med internationella forskare och ... (LBG) är hälsovetenskapens två största utmaningar bristen ...
Breaking Biology Technology:ImmunoCellular Therapeutics Establishes Agreement with Novella Clinical to Conduct ICT-107 Phase 3 Registration Trial in Glioblastoma 2Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 2Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 3Lansering av världens första program för öppen innovation för att utbilda forskare 2Lansering av världens första program för öppen innovation för att utbilda forskare 3
... Reportlinker.com announces that a new market research report ... Biomarkers - Technologies,markets and companies ... follows the broad definition of a biomarker as ... evaluated as an indicator of normal biological or ...
... 2011 Reportlinker.com announces that a new ... catalogue: The 2011 Blood ... Opportunities and Business Expansion Strategies for Suppliers ... During the next ten years, the ...
... YORK, March 7, 2011 NeoStem, Inc. (NYSE Amex: ... operations in the U.S. and China, is pleased to ... Vice President of Strategic Business Development. Jason was formerly ... the firm,s research effort in emerging biotechnology companies. Jason,s ...
Cached Biology Technology:Reportlinker Adds Biomarkers - Technologies, Markets and Companies 2Reportlinker Adds The 2011 Blood Banking Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers 2NeoStem Announces the Addition of Jason Kolbert as Vice President of Strategic Business Development 2NeoStem Announces the Addition of Jason Kolbert as Vice President of Strategic Business Development 3
(Date:7/2/2015)... 2, 2015 Fingerprint Cards has received ... and FPC1155 from the distributor World Peace Industrial Group (WPI), ... in Asia . Deliveries are planned to ... be used by smartphone manufacturers in Asia ... the communicated revenue guidance of approximately 2,200 MSEK for 2015. ...
(Date:6/26/2015)... ATL Technology, LLC, a top provider of electromechanical contract manufacturing ... headquartered in Springville, Utah , has announced ... corporation with locations in Santa Clara, CA ... ). This acquisition will incorporate MedConx,s manufacturing facility ... existing facility in Costa Rica , resulting ...
(Date:6/24/2015)... , June 24, 2015 The biologics safety ... major drivers for the market include growth of the ... new drug launches. Over the years, the number of ... 2001 and 2010, the FDA approved 225 drug applications ... WIPO, Europe accounted for 3,822 ...
Breaking Biology News(10 mins):FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4
... Netherlands,Thursday 25 April 2013: Probiotics could emerge as ... therapy after a new study announced at ... reduced development of the notoriously difficult-to-treat disease. ... preventing the development of HE in 160 cirrhotic ...
... Liver Congress 2013 include results from early in vitro ... (cccDNA), which may form the basis of a cure ... cccDNA is organized into mini-chromosomes within the nucleus of ... availability of efficient therapies against HBV, long-term persistence of ...
... 2013, a novel H7N9 influenza virus was identified in ... in humans, resulting in some deaths. A group of ... Reference Laboratory, State Key Laboratory of Veterinary Biotechnology, Harbin ... investigated the origins of this novel H7N9 influenza virus ...
Cached Biology News:Probiotics found to reduce hepatic encephalopathy 2Novel therapeutic approaches to cure chronic HBV infection 2Novel therapeutic approaches to cure chronic HBV infection 3Source identification of H7N9 influenza virus causing human infections 2Source identification of H7N9 influenza virus causing human infections 3
Duck polyclonal to Cobra venom - Fab Fragment ( Abpromise for all tested applications). Antigen: Snake Venom of N. naja arta...
Anti-human C5a/C5a des-Arg (neo-epitode), Clone 2952, Monoclonal Antibody...
...
Reacts with the 80 kDa fragment of the M-chain of human merosin....
Biology Products: